P.343 (441.3 in the journal) Sodium-Glucose Co-transporter-2 Inhibition Vs. Dipeptidyl peptidase-4 Inhibition in Diabetic Kidney Transplant Recipients: single center experience
Dr. Osama Gheith, Egypt
P.016 A comparative analysis of kidney transplantation outcomes in systemic lupus erythematosus patients with disease flare vs. non-flare groups
Dr. Jin-Myung Kim, Korea
P.273a (320.15 in the journal) Recurrence Of Focal Segmental Glomerulosclerosis Among Kidney Transplant Recipients: Kuwait Experience
Dr. Ahmed A. Denewar, Kuwait
P.017 Comparison of ABO-incompatible kidney transplant outcomes between robot-assisted and open techniques
Dr. Jin-Myung Kim, Korea
P.023 Comparative outcomes of simultaneous versus staged nephrectomy in polycystic kidney disease patients undergoing kidney transplantation
Mr. Pedro H. Oliveira Sr., Brazil
P.024 Impact of diabetic donor kidneys on long-term outcomes in kidney transplant recipients: a propensity score matching analysis
Mr. Pedro H. Oliveira Sr., Brazil
P.035 Longitudinal change patterns in estimated glomerular filtration rate in a European population of living kidney donors
Dr. Manuela B Almeida, Portugal
P.060 Deletion of β-catenin in macrophages alleviates transplanted renal interstitial fibrosis by inhibiting pericyte-to-myofibroblast transformation
Prof. Zijie Wang, People's Republic of China
P.064 Establishment and clinical application of immune risk stratification criteria for kidney transplant recipients
Prof. Puxun Tian, People's Republic of China
P.065 Evaluation of the therapeutic effects of argon inhalation in a renal transplantation model using MHC-inbred CLAWN miniature swine
Hisashi Sahara, Japan
P.067 Gender disparity in kidney transplantation in Mongolia an analysis of the ASTREG WIT KT registry
Dr. Lkhaakhuu L Od-Erdene Od, Mongolia
P.070 Immediate results of kidney transplantation from ABO-incompatible donors
Dr. Nigina B Elmuradova, Uzbekistan
P.115 Human Leukocyte Antigen Distribution Among Kidney Transplant Donors and Recipients: Data
from Central Indian Region
Dr. Amit S Pasari, India
P.116 Kidney Transplantation in Patients with Complement Gene Mutations: A Single-Centre Experience from Central India
Dr. Amit S Pasari, India
P.121 To evaluate the outcomes of right sided laparoscopic donor nephrectomy in Pakistani kidney donors
Dr. Abdul Khalique, Pakistan
P.126 Recurrence of AA amyloidosis in kidney transplant recipients
Dr. Aygul Celtik, Turkey
P.134 Assessment Of Tacrolimus-Based Vs. Cyclosporine-Based Maintenance Immunosuppressive Regimens Among Living Donor Kidney Transplant Recipients With Low Immunological Risk: Single Centre Experience.
Dr. Osama Gheith, Egypt
P.135 Comparison between Tacrolimus-based and cyclosporine-based maintenance immunosuppressive regimens in kidney transplant recipients with functioning grafts beyond 15 years
Dr. Osama Gheith, Egypt
P.140 Urinary tract infection graft outcomes in kidney transplanted patient in Mongolia
Dr. Khishgee Tseren, Mongolia
P.141 Renal vascular disparities among kidney donors, a reterospective study
Dr. Muhammad Tassaduq Khan, Pakistan
P.145 Mortality risk factors and survival outcomes of patients on the kidney transplant waiting list in Tunisia
Prof. Mohamed Mongi Bacha, Tunisia
P.146 Access to kidney transplantation for patients on the deceased donor waiting list in Tunisia: a single-center study
Prof. Mohamed Mongi Bacha, Tunisia
P.147 Impact of the 2011 Tunisian revolution on kidney transplantation accessibility from waiting list: a single center study
Prof. Mohamed Mongi Bacha, Tunisia
P.157 ABO i Kidney Transplant
Dr. Ishthiaque Ahamed, United Arab Emirates
P.158 A comparative study of early versus late initiation of renal replacement therapy in acute kidney injury due to snake envenomation and its impact on short-term and long-term outcome of the kidney function
Dr. Kaushik Mondal Sr., India
P.159 Clinical profile of acute kidney injury after heart transplant
Dr. Aswin Raj, India
P.160 Single-cell Transcriptomics Reveals that Ccl6/Ccr2 Pathway Induce Migration and M2 Polarization among Macrophages in Acute Kidney Injury
Dr. Jiayu Wang, People's Republic of China
P.162 Seroepidemiology of Toxoplasma Gondii in kidney transplant patients
Dr. Sanaz Dehghani, Iran
P.163 Long-term graft survival in a kidney transplant recipient with glioblastoma: Case Report
Dr. Sanaz Dehghani, Iran
P.164 Comparable graft survival of re-transplantation in elderly kidney recipients in regard to rejection
Dr. Hanbi Lee, Korea
P.165 Challenges and Opportunities: Early Outcomes of Elderly Renal Transplant Recipients
Dr. Alex Rogers, United States
P.166 Outcomes of kidney transplantation in older recipients: Is age just a number?
Dr. Vikrant Thakur, United Kingdom
P.169 Renal re-transplantation: An ideal treatment for primary allograft failure
Dr. Negin Khosroabadi, Iran
P.170 Single center experience in clinical and laboratory features of geriatric transplantations
Dr. Funda Salgur, Turkey
P.172 A study of living donor renal transplantation with inconsistent flow cytocross-match (FCXM) and preformed donor-specific antibodies (DSA)
Dr. Osamu Konno, Japan
P.173 The impact of post-transplant non-HLA antibody burden on the occurrence of antibody-mediated rejection and graft loss in non-sensitized pediatric kidney recipients
Dr. Stella Muscianisi, Italy
P.175 Correlation of early graft dysfunction and baseline doppler ultrasound result
Dr. Paolo Angelo R. Igama, Philippines
P.176 PRES as a post-kidney transplant risk: Importance of blood pressure and immunosuppression management
Dr. Elvana Rista, Albania
P.178 Immunologic risk stratification of kidney transplant recipients by combining HLA-eplet MM and PIRCHE-II
Dr. Dongryeol Lee, Korea
P.179 ‘Epitope matching’, the must addition in pre-transplant algorithm
Ms. Dhanashree Shirish Rahalkar, India
P.180 Results of CDC-XM and FCXM cross-match in highly sensitized patients with CKD
Dr. Aida Turganbekova, Kazakhstan
P.181 A program of pre-emptive kidney retransplantation from deseased donors
Dr. Antonio Franco Esteve, Spain
P.182 Real world bioequivalence of prolonged release formulations of tacrolimus in renal transplant recipients. Is a determination needed before switching among them?
Dr. Antonio Franco Esteve, Spain
P.183 Comparison of kidney transplantation outcomes from deceased kidney donors with and without history of cardiac arrest
Dr. Brendon C Cajilla, Philippines
P.184 Evaluation of 4 different initial doses of envarsus in renal transplant recipients de novo. Is there overdose?
Dr. Antonio Franco Esteve, Spain
P.185 Urological complications following the use of a modified ureteral reimplantation technique in kidney transplantation
Marina M Tabbara, United States
P.186 Vascular complications after kidney transplantation when performing the renal artery anastomosis first
Marina M Tabbara, United States
P.187 Other (non-urologic and non-vascular) surgical complications after a modified kidney transplant surgical technique
Marina M Tabbara, United States
P.188 The use of robotically procured living donor kidneys for transplantation in pediatric patients
Marina M Tabbara, United States
P.189 Comparative study of outcome between deceased donor kidney transplantation using standard criteria vs expanded criteria donors: An experience from a single centre in Sri Lanka
Dr. Lasantha Niroshan Seneviratne, Sri Lanka
P.190 Impact of Kidney Donor Profile Index (KDPI) Scores on Post-Transplant Clinical outcomes in King Faisal Specialist Hospital & Research Centre, Riyadh (Single Centre Study)
Dr. Yaser Shah, Saudi Arabia
P.191 The outcomes of the deceased donor kidney transplantation using extended criteria donor
Dr. Ju Ik Moon, Korea
P.192 Infection and cancer screening in potential living donors: Best practices to protect the donor and recipient
Dr. Bassam Saeed, Syrian Arab Republic
P.194 Pediatric kidney transplantation in under-resourced country: A single center experience
Prof. Hala Wannous, Syrian Arab Republic
P.195 The association of phase angle with in-hospital complication after laparoscopic living-donor hepatectomy
Prof. Gaabsoo Kim, Korea
P.197 Patient’s death with a functioning graft (DWF) from infection is a major cause of renal transplant loss – A retrospective study from a single center
Dr. Sanket Patel, India
P.198 Comparison of short term outcomes with and without induction therapy in low risk renal transplant recipients
Dr. Sanket Patel, India
P.199 A cross sectional study of the medium term outcomes in living donor renal transplant recipients developing ATN in the immediate post transplant period
Dr. Sharmila Thukral, India
P.200 Impact of single center kidney Exchange transplantation to increase living donor pool in India: A cohort study
Dr. Hari Shankar Meshram, India
P.201 Paired kidney donation transplant - a 10 year experience from a single centre in northern India
Dr. Rajat Mangal, India
P.202 Comparison of renal volumetry and histological features between standard and marginal donors
Dr. Shunta Hori, Japan
P.204 Laparoscopic hand-assisted donor heminephrectomy in living donor with horseshoe kidney with non-touch technique
Dr. Islam Madadov, Kazakhstan
P.205 The Kidney Donors with Nephrolithiasis: Is It Safe?
Dr. Emre Arpali, United States
P.206 The reasons for potential donor ineligibility in living donor kidney transplants at the Libyan transplant Authority.
A Retrospective single centre cohort study.
Prof. Ehtuish Farag Ehtuish, Libya
P.208a (341.6 in Journal) Insights into kidney paired donation in Brazil: Unveiling donors perspectives
Dr. Gustavo Ferreira, Brazil
P.209 One year pathological and clinical outcomes of recipients of donor exchange kidneys
Dr. Lillian Gaber, United States
P.210 Results of more than 1400 kidney transplants from a living related donor performed at the State Institution "RSSPMCS named after Academician V.Vakhidov", Uzbekistan
Dr. Dildora Nodirovna Komilova, Uzbekistan
P.213 Barriers to kidney transplantation: Single centre experience
Dr. Monisha Simon, India
P.221 A rare Case of Kaposi-Juliusberg’s Syndrome in a kidney transplant patient
Dr. Rihem DAHMANE, Tunisia
P.224 Comparison of Higher Alternative Health Eating Index-Taiwan Scores and Lipid Profiles in Long Term Follow-up Renal Transplant Recipients in Taiwan
Ms. I-Hsin Tseng, Taiwan
P.225 New-onset diabetes after transplantation (nodat) and glucose Metabolism in at-risk patients receiving cyclosporine versus tacrolimus: a randomised controlled trial
Dr. Neeraj Jain, India
P.226 Coronary artery disease assessment using Tc-99m MIBI gated myocardial perfusion scintigraphy prior to kidney transplantation
Dr. Ayse Aktas, Turkey
P.227 Clinical features and outcomes of 20-year kidney transplant survivors
Dr. Takuzo Fujiwara, Japan
P.228 The Immediate Outcome of kidney donors at PKLI, a single center experiene.
Prof. Saeed Akhter, Pakistan
P.229 Case series of multiple myeloma and kidney transplant outcome: Clinical characteristics and long-term follow-up
Dr. Hon Shen Png, Canada
P.230 Outcome of delayed graft function and slow graft function in renal transplant recipients in a tertiary care Centre in eastern India
Dr. Sourav Sadhukhan, India
P.231 Anticoagulant and antiplatelet use in renal transplantation: Is perioperative blood loss and transfusion rates a significant concern?
Mr. John T Black, United Kingdom
P.233 Short-Term Outcomes with No Tapering Tacrolimus to Belatacept Conversion in Renal Transplant Recipients (RTR)
Dr. Adela D. Mattiazzi, United States
P.234 Renal transplantation provides a quality of life benefit in the over 70s
Miss Joanne Devlin, United Kingdom
P.235 Kidney Transplant (KTx) in Jehovah’s Witnesses: ethical implications, management proposal from a single center experience and review of literature
Dr. Marika Morabito, Italy
P.237 Association between estimated glomerular filtration rates at initiation of dialysis and all-cause mortality in kidney transplant recipients with a failing kidney allograft
Dr. Dharshana Sabanayagam, Australia
P.238 Nephrotic syndrome early post kidney transplantation - rare manifestation of acute rejection
Dr. Ritesh Kauntia, India
P.239 Acceptable graft volume and recipient physique ratio in kidney transplant
Dr. Takayoshi Yokoyama, Japan
P.240 Advanced chronic kidney disease in kidney transplant recipients: A national cross-sectional cohort study
Mr. Bojan Medved, Slovenia
P.241 Monocyte to lymphocyte ratio and tacrolimus levels at 2 weeks after kidney transplantation as predictors of mortality among kidney transplant recipients at Dr Sardjito hospital, Indonesia
Dr. Siti Nur Rohmah, Indonesia
P.242 Beyond barriers: Navigating the transplant terrain with pre transplant DSA using low dose desensitisation protocol in live donor renal transplantation.
Dr. Syeda Hurmath, India
P.243 Kidney transplantation outcomes among patients with multiple myeloma – systematic review of case reports and case series
Dr. Hon Shen Png, Canada
P.244 Retrospective comparative analysis of short term outcome of induction agent in kidney transplantation: Thymoglobulin vs Grafalon
Dr. Ritesh Kauntia, India
P.245 Challenges and outcomes with kidney re-transplantation
Dr. Shyam Bansal MD,DM, India
P.247 Impact of age difference between donor and recipient in renal transplantation
Dr. Ji Yoon Choi, Korea
P.254 Outcomes of liver transplantations in patients with alagille syndrome with high pulmonary arterial pressure performed in our center
Dr. Adem Safak, Turkey
P.255 Is oral glucose tolerance test useful in workup for kidney transplantation? To OGTT or not to OGTT?
Prof. Lada Zibar, Croatia
P.256 Improved prognosis in renal transplant recipients by cancer screening
Dr. Yoichi Kakuta, Japan
P.257 Advances in dialysis treatment may improve kidney transplant outcomes
Dr. Yoichi Kakuta, Japan
P.258 Effective financial preparedness for kidney and pancreas transplant patients
Dr. Martin Mai, United States
P.259 Late antibody-mediated rejection with inferior allograft prognosis compared with early rejection: A single-center study
Dr. Jinghong Tan, People's Republic of China
P.260 Impact of pre-operative haemodialysis on transplanted kidney function
Mr. Grigorios Voulalas, United Kingdom
P.261 Serum symphony: harmonizing renal transplants in Argentina
Manuel E. Quirno Costa, Argentina
P.265 Reconsidering the impacts of morbid obesity on kidney transplantation in the age of robotic-assisted kidney transplantation
Dr. Steven A Wisel, United States
P.266 Characteristics of patients started on dialysis after loss of kidney function
Mr. Efstratios Kasimatis, Greece
P.269 Immunoadsorption is efficient in patients who failed to respond to plasma exchange and rituximab for treatment of recurrent FSGS
Prof. Nikolina Bašić Jukić, Croatia
P.270 Oral pH-modified release budesonide for preventing recurrence of IgA nephropathy in kidney transplant recipients: A single center experience
Dr. Bogdan Marian Sorohan, Romania
P.271 Are the recurrent glomerulonephritis (RGN) a negative factor for the long term renal transplant outcome?
Dr. Maria del Carmen Rial, Argentina
P.273 Recurrence of cryocrystalglobulinemia after kidney transplant: Case report
Dr. Wanda Rojas, Argentina
P.274 Histopathological insights and clinical implications of renal allograft biopsies: A comprehensive retrospective analysis from a single-centre study in central India
Dr. Pranjal Kashiv, India
P.277 The relationship between rebound thymic hyperplasia and the risk of rejection in renal transplantation patients
Dr. Burak Yagdiran, Turkey
P.278 Renal vein extension using polyester vascular graft in living donor related renal transplantation a safe and effective technique
Dr. Jestha Marie Bernadette P. de Vera, Philippines
P.280 Comparative analysis of 2- and 3-dimensional laparoscopic donor nephrectomy
Mr. Myltykbay Rysmakhanov, Kazakhstan
P.281 When two may be better than one; a tale of two extremes in kidney transplant. Initial report from a ‘new’ deceased donor transplant programme in the United Arab Emirates
Salwa AlRemeithi, United Arab Emirates
P.283 How effective is combined spinal and epidural anaesthesia (CSEA) for kidney transplantation? Experience from a high-volume program in Nigeria
Dr. Olalekan O Olatise, Nigeria
P.284 Native nephrectomy in autosomal dominant polycystic kidney disease patients for kidney transplantation: Do we really need it?
Prof. Burak Kocak, Turkey
P.286 Non-oncological abdominal surgery not associated with transplantation in kidney transplant recipients: a single center experience
Dr. Hamza Göktuğ Kıvratma, Turkey
P.289 Retrograde venous reperfusion of the kidney – An experimental study
Dr. Yerlan Sultangereiyev, Kazakhstan
P.290 Rapid reduction of mycophenolate mofetil and calcineurin inhibitor dose for treating cytomegalovirus infection in renal transplant patients
Dr. Kuo Jen Lin, Taiwan
P.291 Anterior crescentic incision approach in living donor nephrectomy: Analysis of 436 cases
Dr. Adem Safak, Turkey
P.293 Vascular complexities in renal transplant. Our centre’s experience in 6947 cases
Dr. Tarshid Ali Jahangir, India
P.294 Evaluation of the most common microorganisms causing surgical site infections after renal transplantation
Prof. Daniela Kniepeiss, Austria
P.295 The impact of exercise habits on clinical infection outcomes after kidney transplantation
Dr. Hiroki Kurata, Japan
P.298 Non-autogenous graft reconstruction in an external iliac artery dissection in a post-transplant recipient
Dr. Joseph C. Laygo, Philippines
P.300 Paragonimiasis mimicking ureter stone in living kidney donor
Prof. Young Joo Kwon, Korea
P.302 Results of a national panel survey of black Americans’ knowledge of and attitudes toward live donor kidney transplantation
Dr. Heather M Gardiner, United States
P.303 An exploratory study of patient-provider communication during the medical evaluation for kidney transplantation
Dr. Heather M Gardiner, United States
P.304 Hyporesponsiveness to erythropoiesis-stimulating agents in kidney transplant recipients with late post-transplant anemia
Prof. Junji Uchida, Japan
P.305 Complement C5 inhibition with eculizumab/ravulizumab in kidney transplant patients – A single center experience
Dr. Špela Borštnar, Slovenia
P.306 Are serum erythropoietin levels associated with eGFR in mexican kidney transplant recipients?
Dr. Lucino Bahena Carrera, Mexico
P.308 Insulating effect of thermal barrier bag (OrganPocket ®) on second warm ischemic time during living renal transplantation: Comparison with direct cooling cases
Dr. Yuichi Machida, Japan
P.310 Prevalence of erythrocytosis and associated clinical manifestations in renal transplant recipients
Dr. Adil Manzoor Sr., Pakistan
P.312 Impact of delayed graft function on doppler ultrasound parameters in the early period after kidney transplantation
Dr. Karmen Romozi, Slovenia
P.313 Females are underrepresented on dialysis and on the active list according to the analysis of National Waiting Transplant List
Dr. Jacek Zawierucha, Poland
P.314 Tapering of immunosuppression in recipients with failed kidney transplant – retrospective cohort study
Dr. Barbara Vajdic Trampuz, Slovenia
P.315 The role of comprehensive support in enhancing quality of life and participation after kidney transplantation
Miss Aruzhan Baizhan, Kazakhstan
P.316 17beta-estradiol and methylprednisolone treatment during isolated kidney perfusion has beneficial effects in brain dead females but not in male rats
Miss Marina Vidal dos Santos, Brazil
P.317 Enhancing Medication Adherence in Kidney Transplant Recipients: The impact of Quarterly Pharmacist Counseling
Dr. Young Ju Oh, Korea
P.318 Clinical characteristics of lupus nephritis patients submitted to kidney transplantation in a single center
Dr. Gisele Meinerz, Brazil
P.319 Immunosuppressive medication adherence´s association with microvascular inflammation in protocol biopsies in a kidney transplant Mexican population
Dr. Lucino Bahena Carrera, Mexico
P.320 Nutrition Status Assessment of Long term followed-up in Patients with Renal Transplant Recipients in Taiwan
Prof. I Hsin Lin, Taiwan
P.321 The Differences of Dietary Food and Nutrients Intake between obese and non-obese renal transplant recipients in Taiwan
Mrs. Shih Wei Nien, Taiwan
P.322 Inflammatory bowel disease after kidney transplantation-Two case reports.
Dr. Lan Inoki, Japan
P.323 Hyalinosis lesions in kidney protocol biopsies´s association with adherence to immunosuppressive medication measured using the BAASIS scale in a kidney transplant mexican population
Dr. Lucino Bahena Carrera, Mexico
P.324 The first 63 global kidney exchange transplants: overcoming multiple barriers to transplantation
Michael Rees, United States
P.325 Status of Kidney Transplantation in Bangladesh
Shakib Uz Zaman Arefin, Bangladesh
P.326 Perspectives and experiences of women with a kidney transplant on access to healthcare – an international qualitative study.
Maleeka Ladhani, Australia
P.327 Urinary Vitamin D Binding Protein (VDBP) as a Biomarker in Systemic Lupus Erythematosus Patients with Lupus Nephritis and its Relation to Renal Activity
Dr. Marwa Saleh, Egypt
P.328 Multiple renal veins in donor nephrectomy: Preoperative assessment of feasibility for safe and selective ligation
Akshay Kriplani, India
P.330 Rapid reduction of mycophenolate mofetil and calcineurin inhibitor dose for treating BK polyomavirus virus infection in renal transplant patients
Dr. Sy-Yuan Chen, Taiwan
P.331 Static cold storage using a novel kidney envelope for preservation of donor kidney
Dr. Sy-Yuan Chen, Taiwan
P.332 Are renal cysts a barrier to donation for kidney transplantation?
Dr. Emre Karakaya, Turkey
P.333 Interferon-gamma release test results in organ transplant recipients and donors at Başkent University Faculty of Medicine Hospital
Dr. Sule Akcay, Turkey
P.334 Evaluation of anterior and posterior segment findings after cataract surgery in patients with a history of renal transplantation running title: cataract surgery after renal transplantation
Dr. Umit Eksioglu, Turkey
P.335 Analysing 3534 kidney transplants: Are multiple vessels a barrier to kidney transplantation?
Mr. Ozan Okyay, Turkey
P.336 Management of urologic complications after kidney transplants
Dr. Emre Karakaya, Turkey
P.339 Retrospective analysis of nephrology care in the Republic of Azerbaijan: A single center experience